Article Details
Retrieved on: 2021-08-12 10:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The US Food and Drug Administration (US) has handed AstraZeneca a complete response letter (CRL) regarding its anaemia drug roxadustat.
Article found on: www.pharmatimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here